Greater occipital nerve block for acute treatment of migraine headache

A large retrospective cohort study

Sorcha M. Allen, Farouk Mookadam, Stephen S. Cha, John A. Freeman, Amaal Starling, Martina Mookadam

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Introduction: Greater occipital nerve (GON) blocks are frequently used to treat migraine headaches, although a paucity of supporting clinical evidence exists. The objective of this study was to assess the efficacy of GON block in acute treatment of migraine headache, with a focus on pain relief. Methods: This retrospective cohort study was undertaken between January 2009 and August 2014 and included patients who underwent at least 1 GON block and attended at least 1 follow-up appointment. Change in the 11-point numeric pain rating scale (NPRS) was used to assess the response to GON block. Response was defined as "minimal" (<30% NPRS point reduction), "moderate" (31-50% NPRS point reduction), or "significant" (>50% NPRS point reduction). Results: A total of 562 patients met inclusion criteria; 423 were women (75%). Mean age was 58.6 16.7 years. Of these 562, 459 patients (82%) rated their response to GON block as moderate or significant. No statistically significant relationship existed between previous treatment regimens and response to GON block. GON block was equally effective across the different age and sex groups. Conclusions: Greater occipital block seems to be an effective option for acute management of migraine headache, with promising reductions in pain scores.

Original languageEnglish (US)
Pages (from-to)211-218
Number of pages8
JournalJournal of the American Board of Family Medicine
Volume31
Issue number2
DOIs
StatePublished - Mar 1 2018

Fingerprint

Nerve Block
Migraine Disorders
Cohort Studies
Retrospective Studies
Pain
Therapeutics
Appointments and Schedules
Age Groups

Keywords

  • Migraine headache
  • Nerve block
  • Pain
  • Retrospective studies
  • Treatment outcome

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Family Practice

Cite this

Greater occipital nerve block for acute treatment of migraine headache : A large retrospective cohort study. / Allen, Sorcha M.; Mookadam, Farouk; Cha, Stephen S.; Freeman, John A.; Starling, Amaal; Mookadam, Martina.

In: Journal of the American Board of Family Medicine, Vol. 31, No. 2, 01.03.2018, p. 211-218.

Research output: Contribution to journalArticle

Allen, Sorcha M. ; Mookadam, Farouk ; Cha, Stephen S. ; Freeman, John A. ; Starling, Amaal ; Mookadam, Martina. / Greater occipital nerve block for acute treatment of migraine headache : A large retrospective cohort study. In: Journal of the American Board of Family Medicine. 2018 ; Vol. 31, No. 2. pp. 211-218.
@article{362ffb0fd75d4d259f97cf85e3d4277e,
title = "Greater occipital nerve block for acute treatment of migraine headache: A large retrospective cohort study",
abstract = "Introduction: Greater occipital nerve (GON) blocks are frequently used to treat migraine headaches, although a paucity of supporting clinical evidence exists. The objective of this study was to assess the efficacy of GON block in acute treatment of migraine headache, with a focus on pain relief. Methods: This retrospective cohort study was undertaken between January 2009 and August 2014 and included patients who underwent at least 1 GON block and attended at least 1 follow-up appointment. Change in the 11-point numeric pain rating scale (NPRS) was used to assess the response to GON block. Response was defined as {"}minimal{"} (<30{\%} NPRS point reduction), {"}moderate{"} (31-50{\%} NPRS point reduction), or {"}significant{"} (>50{\%} NPRS point reduction). Results: A total of 562 patients met inclusion criteria; 423 were women (75{\%}). Mean age was 58.6 16.7 years. Of these 562, 459 patients (82{\%}) rated their response to GON block as moderate or significant. No statistically significant relationship existed between previous treatment regimens and response to GON block. GON block was equally effective across the different age and sex groups. Conclusions: Greater occipital block seems to be an effective option for acute management of migraine headache, with promising reductions in pain scores.",
keywords = "Migraine headache, Nerve block, Pain, Retrospective studies, Treatment outcome",
author = "Allen, {Sorcha M.} and Farouk Mookadam and Cha, {Stephen S.} and Freeman, {John A.} and Amaal Starling and Martina Mookadam",
year = "2018",
month = "3",
day = "1",
doi = "10.3122/jabfm.2018.02.170188",
language = "English (US)",
volume = "31",
pages = "211--218",
journal = "Journal of the American Board of Family Medicine",
issn = "1557-2625",
publisher = "American Board of Family Medicine",
number = "2",

}

TY - JOUR

T1 - Greater occipital nerve block for acute treatment of migraine headache

T2 - A large retrospective cohort study

AU - Allen, Sorcha M.

AU - Mookadam, Farouk

AU - Cha, Stephen S.

AU - Freeman, John A.

AU - Starling, Amaal

AU - Mookadam, Martina

PY - 2018/3/1

Y1 - 2018/3/1

N2 - Introduction: Greater occipital nerve (GON) blocks are frequently used to treat migraine headaches, although a paucity of supporting clinical evidence exists. The objective of this study was to assess the efficacy of GON block in acute treatment of migraine headache, with a focus on pain relief. Methods: This retrospective cohort study was undertaken between January 2009 and August 2014 and included patients who underwent at least 1 GON block and attended at least 1 follow-up appointment. Change in the 11-point numeric pain rating scale (NPRS) was used to assess the response to GON block. Response was defined as "minimal" (<30% NPRS point reduction), "moderate" (31-50% NPRS point reduction), or "significant" (>50% NPRS point reduction). Results: A total of 562 patients met inclusion criteria; 423 were women (75%). Mean age was 58.6 16.7 years. Of these 562, 459 patients (82%) rated their response to GON block as moderate or significant. No statistically significant relationship existed between previous treatment regimens and response to GON block. GON block was equally effective across the different age and sex groups. Conclusions: Greater occipital block seems to be an effective option for acute management of migraine headache, with promising reductions in pain scores.

AB - Introduction: Greater occipital nerve (GON) blocks are frequently used to treat migraine headaches, although a paucity of supporting clinical evidence exists. The objective of this study was to assess the efficacy of GON block in acute treatment of migraine headache, with a focus on pain relief. Methods: This retrospective cohort study was undertaken between January 2009 and August 2014 and included patients who underwent at least 1 GON block and attended at least 1 follow-up appointment. Change in the 11-point numeric pain rating scale (NPRS) was used to assess the response to GON block. Response was defined as "minimal" (<30% NPRS point reduction), "moderate" (31-50% NPRS point reduction), or "significant" (>50% NPRS point reduction). Results: A total of 562 patients met inclusion criteria; 423 were women (75%). Mean age was 58.6 16.7 years. Of these 562, 459 patients (82%) rated their response to GON block as moderate or significant. No statistically significant relationship existed between previous treatment regimens and response to GON block. GON block was equally effective across the different age and sex groups. Conclusions: Greater occipital block seems to be an effective option for acute management of migraine headache, with promising reductions in pain scores.

KW - Migraine headache

KW - Nerve block

KW - Pain

KW - Retrospective studies

KW - Treatment outcome

UR - http://www.scopus.com/inward/record.url?scp=85044163390&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044163390&partnerID=8YFLogxK

U2 - 10.3122/jabfm.2018.02.170188

DO - 10.3122/jabfm.2018.02.170188

M3 - Article

VL - 31

SP - 211

EP - 218

JO - Journal of the American Board of Family Medicine

JF - Journal of the American Board of Family Medicine

SN - 1557-2625

IS - 2

ER -